Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : World Heart Corp - WHRT and TSE/WHT -- Ignore unavailable to you. Want to Upgrade?

To: Stang who wrote (303)	11/13/1999 12:55:00 PM
From: RWReeves	Read Replies (2) \| Respond to of 500

ABMD getting the glory Takeover speculation is fueling a nice upward move in competitor ABMD. Seems like a good many Art-Heart people don't even seem to know about WHRT. I think WHRT has the greater depth of knowledge and experience of the two. Message 11904835 RWR

To: Stang who wrote (303)	2/17/2000 3:45:00 PM
From: Stang	Read Replies (3) \| Respond to of 500

WORLD HEART CORPORATION TO HOLD TELEPHONE CONFERENCE CALL FOLLOWING ANNOUNCEMENT OF YEAR END RESULTS FOR THE PERIOD ENDED DECEMBER 31, 1999 OTTAWA, CANADA, February 17 /CNW/ - World Heart Corporation will hold a telephone conference call for shareholders and interested members of the financial community following the release of year end results for the period ended December 31, 1999. The call will take place on Tuesday February 22nd , 2000 and will be hosted by Roderick M. Bryden, President and Chief Executive Officer, who will be accompanied by Dr. Tofy Mussivand, Chairman and Chief Scientific Officer and Ian W. Malone, Chief Financial Officer. The conference call will begin at 4:15 p.m. EST. Interested shareholders and members of the financial community should call 1-888-209-3773 at approximately 4:00 p.m. EST, identifying themselves and asking to participate in the WorldHeart conference call. A replay will be available after 6:00 p.m. on Tuesday February 22, 2000 Please call 1-800-558-5253 The pass code to access the recording is 14472077 (Please note that the replay is only accessible with a touch-tone telephone) WorldHeart is a medical devices business focused on commercialization of artificial heart and related technologies for which worldwide rights were acquired from the University of Ottawa Heart Institute. Continuing research and development of these technologies is carried out under contract to WorldHeart by the Cardiovascular Devices Division of the University of Ottawa Heart Institute Research Corporation, an affiliate of the University of Ottawa Heart Institute. WorldHeart is a public company whose stock trades on the NASDAQ National Market (ticker symbol: WHRT) and The Toronto Stock Exchange (ticker symbol: WHT). -30- For further information: Sandy Armstrong, Media and Public Relations, World Heart Corporation, Tel.: (613) 226-4278, Fax: (613) 226-4744, E-mail: sandy.armstrong@worldheart.com WORLD HEART CORPORATION has 40 releases in this database. newswire.ca Stang